Materials and methods One of the major problems in allograft trans plantation is rejection of the graft, as a result of an immune response mounted by the recipient against alloantigens expressed by the graft [1 ,2]. Owing to their unique anatomical position, endo thelial cells (ECs) are among the first cells of the allograft that are encountered by the recipient's immune system. MHC class-I and class-II anti-ECs and FBs ECs and FBs were isolated from human umbili cal cord vein and foreskin fragments respectively as described previously [20]. Cells were serially subcultured under standard conditions. Passages 3 to 15 were used; no influence of the passage number on the outcome of the experiments was observed. gens expressed by the ECs may activate alloreactive CD8 + and CD4+ T-lymphocyte subsets respectively [3-10]. T-cell activation requires not only engagement of the T-cell receptor-CD3 complex, but also one or more co-stimulatoiy or accessory signals [11-16]. In several in vitro systems, the potent antigen-presenting and co-stimulatory capacities of ECs have been demonstrated [17-19]. In this study we have analysed the accessory signals involved in the proliferation of alloreactive peripheral blood T-lymphocytes induced by allogeneic MHC class-II molecules in vitro. Allogeneic MHC class-II molecules induced by treatment with interferon y (IFN-y) were presented by either ECs or fibroblasts (FBs). The expression of Monocytes and T-cells Allogeneic T-cell-proliferation assay T-cells were cultured in 96-well U-bottomed microtitre plates. Per incubation, 1.5 x 1 0 s T-cells and 5.0 xlO 4 ECs or FBs were added. ECs and FBs were y-irradiated with 4000 rad before addition. In most experiments, HLA class-II expression was induced on ECs or FBs before use by a 3-day incubation with 200 units/ ml IFN-y (a gift from Boehringer-Ingelheim, Ingelheim, Germany). After 5 days of culture, T-cell proliferation was measured as [3H]thymi dine incorporation. T-cell-EC interactions. Antibodies mAbs used for inhibition experiments and/or Abbreviations used: EC, endothelial cell; IFN-y; inter feron y; FB, fibroblast; mAb, monoclonal antibody; ICAM, intercellular adhesion molecule; VCAM, vascu lar cell adhesion molecule; LFA, lymphocyte-functionassociated antigen. *To whom correspondence should be addressed.
Monocytes and T-cells were isolated as described previously [20] [21] [22] . Briefly, leucocyteenriched cell suspensions were obtained from healthy volunteers by cytapheresis. Mononuclear cells were isolated from these suspensions by centrifugation on Ficoll (density 1.077 g/ml; Pharmacia, Uppsala, Sweden), and monocytes and lymphocytes were subsequently separated by counterflow centrifugation. T-cells were isolated from the lymphocyte fraction by rosetting with 2-aminoethylisothiouronium bromide-treated sheep red blood cells. Monocytes as well as T-cells were cryopreserved in liquid nitrogen until use.
co-stimulatory molecules on both these cell types was compared. The T-cell-proliferation-inhibiting effect of a panel of antibodies directed against co-stimulatory molecules expressed by the ECs or against their counterstructures on the T-cells was assessed. Distinct inhibition of T-cell proliferation was observed with mono clonal antibodies (mAbs) directed against CD2, lymphocyte-function-associated antigen (LFA)-3, LFA-1 or a combination of anti-[intercellular adhesion molecules (ICAM)-l and -2]. We con clude that CD2-LFA-3 and LFA-l-ICAM inter actions are crucially involved in allogeneic
Immunofluorescence from flasks non-enzymically. Cells were washed and incu bated with mAb at 0°C in suspension, stained with FITC-conjugated sheep anti-mouse anti body, and analysed using a flow cytometer. Two mAbs against CD2 were inhibitory up to 55-85%. This inhibition was, however, only partially mirrored by the inhibition obtained with mAbs directed against the endo thelial counterpart, LFA-3. mAbs directed against two alternative counterstructures of CD2, CD48 and CD59, were not inhibitory. Of the third co-stimulatoiy couple investigated, VLA- [22,28-30 ]. In the alloge neic situation, the interactions between lympho cytes and the endothelium are more complex, In vivo, they occur in vascularized allografts, where recipient lymphocytes enter the graft via the bloodstream, and encounter donor ECs. Via adhesion events probably similar to or identical with those taking place in inflammatory lymphocyte-vessel wall interactions, endothelium will be extravasation into the allogeneic tissue. In addi tion to the molecular interactions that occur in the autologous situation, MHC class-I and class- evidence [7,10,31-34 ]. In this study we investi gated the role of co-stimulatory molecules in the induction of allogeneic T-cell activation, using an in vitro co-culture system with human umbilical ECs and purified peripheral T -" Human FBs, induced by IFN-y to express MHC class II molecules, were unable to induce a T-eell response, confirming previously published data [35] [36] [37] . We therefore conclude that accès soiy signals, provided by ECs, play a crucial addi tional role. We 
Results

Analysis of antigen expression on human ECs and FBs before and after treatment with IFN-y
Expression of MHC class-I and class-II antigens and of co-stimulatoiy molecules was determined immunofluorescence metry analysis. Both MHC class-I antigens constitutively, and did not express class-II antigens. Treatment with IFN-y increased class-I antigen expression, especially both ECs and FBs which was hardly affected by treatment with IFN-y. Vascular cell adhesion molecule (VCAM)-l and E-selectin were absent from all the cells tested, as was the B7/BB1 molecule (results not shown). ICAM-1 was expressed on a subpopulation of untreated ECs and FBs, and was considerably up-regulated by treatment with IFN-y. ICAM-2 was constitutively expressed on ECs but not on FBs, and was not by treatment with IFN-y not
Allogeneic HLA class-II antigen expression on ECs is necessary, but not sufficient for induction of T-cell proliferation
Both untreated and IFN-y-treated ECs and FBs were cultured in the presence of purified allogeon ECs, and induced a marked class-II antigen neic peripheral blood T-cells. T-cell proliferation expression on both ECs and FBs (Figure 1). The was determined for different combinations of T-cell, FB and EC donors. A representative experiment is shown in Figure 2. Untreated ECs induced only marginal T-cells proliferation, expression levels of HLA class-I and -II mole cules on IFN-y-treated FBs were somewhat lower than, but comparable with, those on IFNy-treated ECs. The expression profiles of co-stimulatoiy molecules on ECs and FBs were very similar. LFA-3 had a low expression level on ranging in these experiments between a 3-and 38-fold increase in [3H]thymidine uptake as compared with T-cells alone. ECs treated with
4/VCAM-l, only the anti-VLA-/? mAb was moderately inhibitory. Almost complete blockage of T-cell proliferation could be observed with a cocktail of all mAbs directed against adhesion molecules on the T-cell and, to a lesser extent, by blocking adhesion molecules on the endothe lial cells.
Discussion
Numerous aspects of EC-mediated activation of T-cells have number of previous in a (reviewed in [17-19]). Two types of interaction have to be : those occurring and those logous xenogeneic cells. rl have been the focus of attention during the past autologous few years. Several studies have importance of interactions between CD2 LFA-3 molecules as a source of EC-derived co-stimulatory activity
II antigens expressed by the vascular endo thelium may deliver initial activation and proliferation signals to recipient T-lymphocytes. The notion of T-cell activation by allogeneic ECs is supported by a large body of experimental
of T-cells by ECs. Similar itions to those
; m in *t were we in T-cell [22] . 
Introduction
Lymphocyte-endothelial interactions are bidirec tional, complex and dynamic. Contact with T-cells can change endothelial behaviour [1], and contact with endothelial cells can change T-cell behaviour (reviewed in [2]). Studies in the latter area have focused primarily on the ability of endothelial cells to serve as alloantigen-presenting cells (APCs) for T-cells. This may have obscured other more subtle effects of endothelial cells on T-cell behaviour. We have developed gonadal vein endothelial cell (GVEC) lines from cadaver organ donors that can be obtained along with permits
autologous splenocytes an examination of non-* lymphocyte-endothelial interactions, experimental system, we have re ne ie a nonconventional mechanism of T-cell co-stimulation that involves interleukin (IL)-2 and endothelial cell contact.
